If you are a scientist performing cell therapy research using hematopoietic stem and progenitor cell (HSPC) sources, you know how important it is to start with high-quality materials with a large starting yield of CD34+ cells.
In this talk, Saba Aslam (Product Manager, Primary Cells) and Dr. Annie Bargsten (Field Application Scientist, Primary Cells) will introduce STEMCELL Technologies’ mobilized leukopaks and new products that support full workflows that include cell isolation, CD34+ cell expansion, differentiation, genome editing, and analysis. This webinar will also cover sources of CD34+ cells, different mobilizing agents, and detailed methods for processing mobilized leukopaks to isolate CD34+ cells.
Key learning objectives will include:
- An overview of CD34+ cells, their tissue sources, and applications
- A technical overview of mobilizing agents
- Different sources of CD34+ cells, including cord blood, bone marrow, and peripheral blood
- How to process a mobilized leukopak for CD34+ isolation
- Downstream workflow products for isolation, expansion, differentiation, genome editing, and analysis